Expert review of pharmacoeconomics & outcomes research

Expert Rev Pharmacoecon Outcomes Res ISSN 1744-8379 391 views

Indexed In

ncbi ulakbim sci soc

Publications

6

ULAKBİM MEP: 0.644 Ödeme: 3220 Yılı: 2020

Details

Abbreviated Name: expert rev pharmacoecon outcomes res
ISSN: 1744-8379

Publications/Year

Top Clicked Bibliographies from Search

4

Estimating the money flow in the economy attributed to rotavirus disease and vaccination in the Netherlands using a Social Accounting Matrix (SAM) framework.

2019 310 clicks

1

Increased burden of disease and role of health economics: Asia-pacific region.

2019 306 clicks

2

A case study applying a novel approach to estimate the social impact of a medical innovation - the use of secukinumab for psoriatic arthritis in Germany.

2019 286 clicks

5

impact of atherosclerotic cardiovascular disease on healthcare resource utilization and costs in patients with type 2 diabetes mellitus in a real-world setting

2020 272 clicks

3

Generic atorvastatin and rosuvastatin in the South Korean market: time of introduction in relation to manufacturer characteristics.

2019 245 clicks

6

Barriers and facilitators of exploiting the potential of value-added medicines.

2020 237 clicks